ZUG, Switzerland, Aug. 26, 2019 /PRNewswire/ -- This is a fundamental re-engineering of our award-winning first and only smart watch with an Automatic Self-Charging battery system, providing world record power autonomy. It has groundbreaking features, because the more you move, the more you transform 100% clean kinetic energy into

SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today announced Marty Duvall, chief executive

DENVER, Aug. 26, 2019 /PRNewswire/ -- CBD of Denver, Inc. (OTC CBDD) is pleased to announce the relaunch of our E-Commerce Web Site www.blackpearlcbd.com.  The website wi

SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various cancers including prostate, colorectal and leukemia, today announced the presentation of positive clinical data fr

SAN DIEGO, Aug. 26, 2019 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will participate in the 2019 Wells Fargo Healthcare Conference in Boston, MA.  Dr. Helen Torley, president and chief executive officer,

HOUSTON, Aug. 26, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that it has engaged argodesign, an award-winning

AUSTIN, Texas, Aug. 26, 2019 /PRNewswire/ -- Leading health and wellness solutions provider, Salutoceuticals, LLC, announced the launch of their new Sleep Remedy formula designed for more effectiveness and efficiency.

WOODCLIFF LAKE, N.J., Aug. 26, 2019 /PRNewswire/ -- Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate appointment of Priya Chaturvedi, Ph.D., as Vice President, Global Clinical Quality Assurance.

SHELTON, Conn., Aug. 26, 2019 /PRNewswire/ -- NanoViricides, Inc. (NYSE Amer.: NNVC) (the "Company"), reports that it has filed its annual report (Form 10-K) for the financial year ending June 30, 2019, with the Securities and Exchange Commission (SEC) on Friday, August 23, 2019. The report can be acce

WELLESLEY, Mass., Aug. 26, 2019 /PRNewswire/ -- 4G Clinical today announced its recognition as a finalist in the 2019 European Innovations Awards for its cutting-edge approach to cohort management within its